Skip to main content
Kuros Biosciences AG (SWX:KURN)
Switzerland flag Switzerland · Delayed Price · Currency is CHF
21.34
-0.58 (-2.65%)
Apr 29, 2026, 11:01 AM CET

Kuros Biosciences AG Revenue

In the year 2025, Kuros Biosciences AG had annual revenue of $146.06M USD with 71.51% growth. Kuros Biosciences AG had revenue of $82.58M in the half year ending December 31, 2025.

Revenue
$146.06M
Revenue Growth
+71.51%
P/S Ratio
7.41
Revenue / Employee
$820.55K
Employees
178
Market Cap
858.72M CHF

Revenue Chart

* This company reports financials in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025146.06M60.90M71.51%
Dec 31, 202485.16M45.30M113.65%
Dec 31, 202339.86M20.41M104.92%
Dec 31, 202219.45M4.30M28.35%
Dec 31, 202115.15M10.59M231.96%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Roche Holding AG 63.36B
Novartis AG 44.94B
Galderma Group AG 4.16B
Lonza Group AG 6.53B
Cosmo 96.99M
PolyPeptide Group AG 362.47M
Aevis Victoria 1.04B
SKAN Group AG 333.34M
Revenue Rankings

Kuros Biosciences AG News

More News